Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.670
Buy
RSI(14)
66.362
Neutral
STOCH(KDJ)(9,3,3)
63.896
Neutral
ATR(14)
2.253
High Vlolatility
CCI(14)
137.171
Buy
Williams %R
32.927
Buy
TRIX(12,20)
1.013
Sell
StochRSI(14)
66.828
Neutral
Search
Conmed Corp
CNMDAdd to Watchlist
46.300USD
-0.670-1.43%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.39BMarket Cap
26.11P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.43%
5 Days
+8.48%
1 Month
+36.86%
6 Months
+18.08%
Year to Date
+14.04%
1 Year
-11.46%
Key Figures
45.600Open
46.780High
641.52KVolume
26.11P/E TTM
9.79P/E Dynamic
0.400Dividend TTM
2.13%Turnover Ratio
46.980Prev. Close
45.240Low
13.93MTurnover
10.54P/E Static
1.37P/B
0.86%Div Yield TTM
2.38%ROA
60.35052wk High
0.93Volume Ratio
132.42MNet Profit
30.14MShares
1.7733EPS TTM
0.93Beta
5.50%ROE
33.21052wk Low
3.28%Amplitude
57.49%Gross Margin
1.39BMarket Cap
13.56Reward/Risk
2.49%Risk Rate
TradingKey Stock Score of Conmed Corp
Currency: USD Updated: 2026-07-31Key Insights
Conmed Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 38 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 45.60.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Conmed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Conmed Corp Highlights
StrengthsRisks
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 18.63%.
Fairly Valued
The company’s latest PE is 26.11, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 34.51M shares, decreasing 16.95% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 21.68K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.57.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
45.600
Target Price
-1.51%
Upside Space
Conmed Corp News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
7
analysts
Hold
Current Rating
45.600
Target Price
-1.51%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
54
Total
5
Median
7
Average
Company name
Ratings
Analysts
Conmed Corp
CNMD
7
Apple Inc
AAPL
48
Ge Vernova Inc
GEV
38
Tapestry Inc
TPR
24
Verisk Analytics Inc
VRSK
20
Avantor Inc
AVTR
19
1
2
3
...
11
Indicators
Moving Average
Indicators
Value
Direction
MA5
44.850
Buy
MA10
43.553
Buy
MA20
41.440
Buy
MA50
37.419
Buy
MA100
37.127
Buy
MA200
39.905
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Conmed Corp Info
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Ticker SymbolCNMD
CompanyConmed Corp
CEOBeyer (Patrick J)
Websitehttps://www.conmed.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52771.700
+393.700 (+0.75%)
28540.100
+379.200 (+1.35%)
7534.100
+59.000 (+0.79%)
14651.000
-98.000 (-0.66%)
63630.000
+778.000 (+1.24%)
6406.700
+41.300 (+0.65%)
78.752
-7.182 (-8.36%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4065.170
+23.740 (+0.59%)
FAQs
What is the current price of Conmed Corp (CNMD)?
The current price of Conmed Corp (CNMD) is 46.30.
What is the symbol of Conmed Corp?
The ticker symbol of Conmed Corp is CNMD.
What is the 52-week high of Conmed Corp?
The 52-week high of Conmed Corp is 60.35.
What is the 52-week low of Conmed Corp?
The 52-week low of Conmed Corp is 33.21.
What is the market capitalization of Conmed Corp?
The market capitalization of Conmed Corp is 1.39B.
Is Conmed Corp (CNMD) currently rated as Buy, Hold, or Sell?
According to analysts, Conmed Corp (CNMD) has an overall rating of signal_hold, with a price target of 45.60.
What is the Earnings Per Share (EPS TTM) of Conmed Corp (CNMD)?
The Earnings Per Share (EPS TTM) of Conmed Corp (CNMD) is 1.52.